Clinical Trials Directory

Trials / Sponsors / CNBG-Virogin Biotech (Shanghai) Ltd.

CNBG-Virogin Biotech (Shanghai) Ltd.

Industry · 8 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingClinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma
Primary Hepatocellular Carcinoma
Phase 1 / Phase 22023-11-30
RecruitingClinical Study of VG161 in the Treatment of Advanced Bone and Soft Tissue Sarcoma
Sarcoma
Phase 22023-07-18
UnknownA PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
SARS-CoV-2 Infection
Phase 22023-07-10
UnknownA Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
SARS-CoV-2 Infection
Phase 12023-03-10
RecruitingClinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer
Metastatic Gastric Cancer
Phase 1 / Phase 22022-11-17
RecruitingClinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma
Advanced Intrahepatic Cholangiocarcinoma
Phase 22022-03-19
UnknownClinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumor
Phase 12021-04-14
RecruitingClinical Study of VG161 in Subjects with Advanced Primary Liver Cancer
Primary Liver Cancer
Phase 12021-03-16